Literature DB >> 17658994

Autoimmunity as an aetiological factor in vitiligo.

N Rezaei1, N G Gavalas, A P Weetman, E H Kemp.   

Abstract

Vitiligo is a common dermatological disorder characterized by the presence on the skin of depigmented macules resulting from the destruction of cutaneous melanocytes. Autoimmunity is an important hypothesis with regard to vitiligo aetiology and the evidence for autoimmune responses being involved in the pathogenesis of this disorder will be discussed in the present review. All immune system compartments, including innate and adaptive immunity have been implicated in vitiligo development. Particularly relevant are autoantibodies and autoreactive T cells in vitiligo patients that have cytotoxic effects upon pigment cells. Furthermore, predisposition to vitiligo appears to be associated with certain alleles of the major histocompatibility complex class II antigens as well as with other autoimmune-susceptibility genes. Moreover, the association of vitiligo with autoimmune disorders, the animal models of the disease, and the positive response to immunosuppressive therapeutic agents emphasize the role of autoimmunity in the development of this disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658994     DOI: 10.1111/j.1468-3083.2007.02228.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  31 in total

1.  Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

2.  Multiple autoimmune syndromes associated with psoriasis: a rare clinical presentation.

Authors:  Sadia Masood; Sara Sajid; Asif Jafferani; Saadia Tabassum; Sobia Ansar
Journal:  Oman Med J       Date:  2014-03

Review 3.  Vitiligo in adults and children: surgical interventions.

Authors:  Rubeta Matin
Journal:  BMJ Clin Evid       Date:  2015-03-20

4.  Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.

Authors:  Ying Jin; Stanca A Birlea; Pamela R Fain; Katherine Gowan; Sheri L Riccardi; Paulene J Holland; Dorothy C Bennett; Deborah M Herbstman; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanny van Geel; Jo Lambert; Andreas Overbeck; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2011-02-17       Impact factor: 8.551

Review 5.  Vitiligo in adults and children.

Authors:  Rubeta Matin
Journal:  BMJ Clin Evid       Date:  2011-03-28

6.  Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin.

Authors:  Ola Ahmed Bakry; Magda Mostafa Hagag; Mona Abd El Halim Kandil; Wafaa Ahmed Shehata
Journal:  J Clin Diagn Res       Date:  2016-12-01

7.  Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes.

Authors:  Yajun Zhang; Ling Liu; Liang Jin; Xiuli Yi; Erle Dang; Yang Yang; Chunying Li; Tianwen Gao
Journal:  J Invest Dermatol       Date:  2013-06-14       Impact factor: 8.551

8.  3-Methyladenine DNA glycosylase is important for cellular resistance to psoralen interstrand cross-links.

Authors:  Ayelet Maor-Shoshani; Lisiane B Meira; Xuemei Yang; Leona D Samson
Journal:  DNA Repair (Amst)       Date:  2008-06-20

9.  Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8.

Authors:  Stanca A Birlea; Katherine Gowan; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2009-11-05       Impact factor: 8.551

10.  Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.

Authors:  Yunqing Ren; Sen Yang; Shengxin Xu; Min Gao; Wei Huang; Tianwen Gao; Qiaoyun Fang; Cheng Quan; Chi Zhang; Liangdan Sun; Yanhua Liang; Jianwen Han; Zhimin Wang; Fengyu Zhang; Youwen Zhou; Jianjun Liu; Xuejun Zhang
Journal:  PLoS Genet       Date:  2009-06-19       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.